Open AccessS119: PRELIMINARY RESULTS OF A PHASE 1 STUDY IN HEALTHY SUBJECTS ADMINISTERED INCLACUMAB, A FULLY HUMAN IGG4 ANTI‐P‐SELECTIN MONOCLONAL ANTIBODY IN DEVELOPMENT FOR TREATMENT OF SICKLE CELL DISEASE
Author(s) -
Mayer C,
Cooper D,
Redfern A,
Geng X,
Shi J,
Zutphenvan Geffen M,
Kuan I,
Koek K,
Kastrissios H,
Patel K,
Davis M,
Yue P
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000821444.06029.7c
Subject(s) - medicine , cohort , pharmacokinetics , gastroenterology , pharmacology